Codex Genetics logo — Unraveling your uniqueness

Codex Genetics

Unraveling your uniqueness

Founded 2013 Hong Kong S.a.r. Hong Kong S.a.r. 12 employees Seed Total: $41.25K Biotechnology

General Information

Company Name Codex Genetics
Founded Year 2013
Location Hong Kong S.a.r. Hong Kong S.a.r. +1
Employees 12
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Codex Genetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Codex Genetics

Codex Genetics Codex Genetics, founded in 2013 Q1 by scientists specialized in genomics and bioinformatics, aims to personalize cancer treatment through its cutting-edge technology. The company's flagship product, GENESIS, is a cancer genetics test developed using next generation sequencing. Codex's growing pharmacogenomics database provides valuable insights into individual tumor causes, enabling tailored treatment for cancer patients. Their clinical pharmacogenomics platform uses individual genetic information to inform treatment options and predict drug responses. By offering two clinically actionable genetic tests for cancer and other FDA-approved diseases, Codex supports clinicians in providing personalized medication in the realm of "Precision Medicine." The company received a $41.25K Seed Round investment on 01 January 2014 from Cyberport Hong Kong. With its focus on biotechnology, Codex Genetics is headquartered in Hong Kong S.a.r.

Taxonomy: genomics, bioinformatics, next generation sequencing, cancer genetics, pharmacogenomics, precision medicine, personalized medication, Asian-specific genetic analysis, Exome sequencing technology, clinical pharmacogenomics platform, medical professionals, precision oncology, cancer treatment, genetic testing, data interpretation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1 •••• •••• 01 Jan 2014

Codex Genetics Alternatives & Competitors

Codex Genetics vs
Precision Genetics
Precision Genetics United States

Leveraging the power of genomics to advance precision medicine for better prescribing outcomes for p...

29 employees
Biotechnology, Pharmaceutical
Codex Genetics vs
PreventionGenetics
PreventionGenetics United States

Improving lives through genetic testing.

185 employees
Biotechnology, Health Care
Codex Genetics vs

pharmacogenetics, pharmacogenomics, precision medicine, diagnostic testing, genetics testing, gene-d...

9 employees
Biotechnology, Health Care

FAQ About Codex Genetics

Unraveling your uniqueness
Codex Genetics was founded in 2013.
Codex Genetics is headquartered in Hong Kong S.a.r..
Codex Genetics operates in the following industries: Biotechnology.
Codex Genetics has approximately 12 employees.
Codex Genetics has completed 1 funding round, raising a total of $41.25K. The latest funding stage is Seed.
Top alternatives and competitors to Codex Genetics include Precision Genetics, PreventionGenetics, RPRD Diagnostics, genomiQa Pty Ltd, Genekor Medical S.A.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Codex Genetics and Precision Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Codex Genetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy